Skites Pharma Private Limited, a active private limited company, was established on 16 March 2017 in Mumbai, Maharashtra, India. Engaging in pharmaceutical retailers & distributors within the trade sector, it holds CIN: U24304MH2017PTC292537. Registered under ROC Roc Mumbai. it is unlisted. It has an authorized capital of ₹7.00 Cr and a paid-up capital of ₹5.94 Cr.
It upholds a compliant status. Employing 459 professional, Its leadership includes Samir Jayantilal Shah (Director), Rohan Mahesh Shah (Director), Mahesh Kantilal Shah (Director). Past directors included Hiroshi Yonenaga, Eishi Maekawa, Mahesh Kantilal Shah. It holds ₹79.92 Cr open charges and no settled loans. Its latest AGM occurred on 25 September 2025, with the balance sheet filed on 31 March 2025. It is based at Flr-G, 15, Mehta Mahal, P L Khandke Marg Mathew Road, Opera House, Girgaon, Mumbai, Maharashtra, 400004.
U24304MH2017PTC292537
292537
16 March 2017
₹7.00 Cr
₹5.94 Cr
Roc Mumbai
Unlisted
Active
Explore comprehensive insights into Skites Pharma Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Samir Jayantilal Shah | Director | 16 Mar 2017 | Current |
| Rohan Mahesh Shah | Director | 16 Mar 2017 | Current |
| Mahesh Kantilal Shah | Director | 13 Feb 2018 | Current |
| Yusuke Kumaki | Director | 27 Jun 2025 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 16 Jul 2021 | Past |
| Pramod Abcsdd | Director | 27 Jun 2025 | Past |
| Pramod Abcsdd | Additional Director | 29 Sep 2018 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Skites Pharma Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 39.55% increase. The company also saw a slight improvement in profitability, with a 0.5% increase in profit. The company's net worth observed a substantial decline by a decrease of 13.56%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2023, Skites Pharma had a promoter holding of 100.00%. The company had 4 Subsidiaries. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹799,200,000.00
₹0
| Date | Lender | Amount | Status |
|---|---|---|---|
| 22 Jun 2018 | Hdfc Bank Limited | ₹79.92 Cr | Open |
Explore comprehensive loan charge details -
Skites Pharma has a workforce of 459 employees as of Apr 03, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Skites Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Skites Pharma's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
The activity Skites Pharma Private Limited last Annual general meeting of members was held on 25 Sep 2025 as per latest MCA records. was completed.
The activity Yusuke Kumaki was appointed as a Director was appointed as a Director on 27 Jun 2025 & has been associated with this company since 5 months 7 days . was completed.
Progress on Skites Pharma Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Mumbai. was documented.
Progress on A charge with Hdfc Bank Limited of Rs. 79.92 Cr registered on 22 Jun 2018 with Charge ID 100194077 was modified on 22 Jul 2022. was documented.
A charge with Hdfc Bank Limited amounted to Rs. 79.92 Cr with Charge ID 100194077 was registered on 22 Jun 2018. was recorded as a recent event.
The activity Mahesh Kantilal Shah was appointed as a Director was appointed as a Director on 13 Feb 2018 & has been associated with this company since 7 years 9 months . was completed.
The CIN of Skites Pharma Private Limited is U24304MH2017PTC292537.
Skites Pharma Private Limited is headquartered at Flr-G, 15, Mehta Mahal, P L Khandke Marg Mathew Road, Opera House, Girgaon, Mumbai, Maharashtra, 400004.
Skites Pharma Private Limited was incorporated on 16 March 2017.
The current directors of Skites Pharma Private Limited are
The primary industry of Skites Pharma Private Limited is Trade.
Skites Pharma Private Limited is unlisted.
The authorized capital of Skites Pharma Private Limited is ₹7.00 Cr, and the paid-up capital is ₹5.94 Cr.
The compliance status of Skites Pharma Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX